HPLC method for the determination of penciclovir in human plasma and application to a bioequivalence study.

A simple, specific, and accurate high-performance liquid chromatographic method, using UV detection for the determination of penciclovir in human plasma, is described. Chromatographic separation is performed on a BDS-C(18) column using a mixture of phosphate buffer (20mM, pH adjusted to 7.5 with phosphoric acid), methanol, and acetonitrile (94:3:3, v/v/v) as mobile phase. The wavelength of the UV detector is set at 254 nm. The flow-rate is 1.0 mL/min. The assay is linear over the concentration range of 0.1-5.0 microg/mL for penciclovir (r > 0.9996). The limit of quantitation for penciclovir in human plasma is 0.1 microg/mL. The relative standard deviation is less than 7.0% for all the analytes. The method is successfully applied to a randomized crossover bioequivalence study of two different famciclovir capsules in 20 healthy volunteers.

[1]  Ji-Hyung Seo,et al.  Development and validation of a high-performance liquid chromatography-tandem mass spectrometry for the determination of penciclovir in human plasma: application to a bioequivalence study. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  Y. Daali,et al.  Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  K. H. Kim,et al.  Synthesis and evaluation of 2-amino-9-(3-acyloxymethyl-4-alkoxycarbonyloxybut-1-yl)purines and 2-amino-9-(3-alkoxycarbonyloxymethyl-4-alkoxycarbonyloxybut-1- yl)purines as potential prodrugs of penciclovir. , 1999, Bioorganic & medicinal chemistry.

[4]  B. Korba,et al.  Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells , 1996, Antimicrobial agents and chemotherapy.

[5]  R. Hannah,et al.  Comparison of high-performance liquid chromatography and capillary zone electrophoresis in penciclovir biodegradation kinetic studies. , 1995, Journal of chromatography. B, Biomedical applications.

[6]  C. Filer,et al.  Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  W. Prince,et al.  Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. , 1994, The Journal of antimicrobial chemotherapy.

[8]  L. Benet,et al.  Pharmacokinetics of Famciclovir in Man , 1993 .

[9]  D. Sutton,et al.  Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16 , 1993, Antimicrobial Agents and Chemotherapy.

[10]  D. Sutton,et al.  Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir] , 1989, Antimicrobial Agents and Chemotherapy.

[11]  D. Sutton,et al.  Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties. , 1989, Journal of medicinal chemistry.

[12]  R. Hodge,et al.  Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells , 1989, Antimicrobial Agents and Chemotherapy.

[13]  D. Pierce,et al.  High-performance liquid chromatographic method for the determination of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL-39123) in human plasma and urine. , 1989, The Analyst.

[14]  D. Sutton,et al.  Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals , 1988, Antimicrobial Agents and Chemotherapy.

[15]  D. Sutton,et al.  Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture , 1987, Antimicrobial Agents and Chemotherapy.